Yung Chyung, MD

Articles by Yung Chyung, MD

The Outlook for Apitegromab and Its Phase 3 Trial: Yung Chyung, MD

July 25th 2021

The chief medical officer of Scholar Rock discussed the upcoming phase 3 trial for apitegromab in SMA and whether a successful trial would warrant FDA submission.

Identifying Unmet Needs in Spinal Muscular Atrophy: Yung Chyung, MD

ByYung Chyung, MD

July 20th 2021

The chief medical officer of Scholar Rock discussed the greatest areas of concern for patients with SMA and why most of these issues exist in the diagnostic stage.

Treating SMA Using a Layered Therapy Approach: Yung Chyung, MD

ByYung Chyung, MD

July 12th 2021

The chief medical officer of Scholar Rock detailed the additive benefits apitegromab has in treating SMA when used with previously approved nusinersen.

Apitegromab’s Potential in Treating SMA: Yung Chyung, MD

ByYung Chyung, MD

July 5th 2021

The chief medical officer of Scholar Rock discussed topline results from the phase 2 TOPAZ study of apitegromab in patients with spinal muscular atrophy.

Yung Chyung, MD

Articles by Yung Chyung, MD

The Outlook for Apitegromab and Its Phase 3 Trial: Yung Chyung, MD

Identifying Unmet Needs in Spinal Muscular Atrophy: Yung Chyung, MD

Treating SMA Using a Layered Therapy Approach: Yung Chyung, MD

Apitegromab’s Potential in Treating SMA: Yung Chyung, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential

NeuroVoices: Gerald Maguire, MD, on Raising Awareness of the Neurobiology of Stuttering

De-Escalation Strategies in Multiple Sclerosis: Oral Therapies and Cladribine

Trappsol Cyclo Shows Promising Results in Newborns With Niemann Pick Disease Type C1

The Process of Diagnosing Stuttering and Implementing Early Intervention: Gerald Maguire, MD